These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 22565545)
1. Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response. Shrestha S; Wiener H; Shendre A; Kaslow RA; Wu J; Olson A; Bowles NE; Patel H; Edberg JC; Portman MA Circ Cardiovasc Genet; 2012 Jun; 5(3):309-16. PubMed ID: 22565545 [TBL] [Abstract][Full Text] [Related]
2. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease. Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416 [TBL] [Abstract][Full Text] [Related]
3. FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response. Makowsky R; Wiener HW; Ptacek TS; Silva M; Shendre A; Edberg JC; Portman MA; Shrestha S Pharmacogenet Genomics; 2013 Sep; 23(9):455-62. PubMed ID: 23778324 [TBL] [Abstract][Full Text] [Related]
4. The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Biezeveld M; Geissler J; Merkus M; Kuipers IM; Ottenkamp J; Kuijpers T Clin Exp Immunol; 2007 Jan; 147(1):106-11. PubMed ID: 17177969 [TBL] [Abstract][Full Text] [Related]
6. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242 [TBL] [Abstract][Full Text] [Related]
7. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya. Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365 [TBL] [Abstract][Full Text] [Related]
8. Fc-gamma IIIa-V158F receptor polymorphism contributes to the severity of Guillain-Barré syndrome. Hayat S; Babu G; Das A; Howlader ZH; Mahmud I; Islam Z Ann Clin Transl Neurol; 2020 Jun; 7(6):1040-1049. PubMed ID: 32484314 [TBL] [Abstract][Full Text] [Related]
9. High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study. Shendre A; Wiener HW; Zhi D; Vazquez AI; Portman MA; Shrestha S Genes Immun; 2014 Dec; 15(8):534-42. PubMed ID: 25101798 [TBL] [Abstract][Full Text] [Related]
10. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behçet's disease: do they have any clinical implications? Aksu K; Kitapcioglu G; Keser G; Berdeli A; Karabulut G; Kobak S; Ozmen M; Inal V; Kabasakal Y; Oksel F; Kocanaogullari H; Doganavsargil E Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S77-83. PubMed ID: 19026120 [TBL] [Abstract][Full Text] [Related]
11. Significant differences in FcγRIIa, FcγRIIIa and FcγRIIIb genes polymorphism and anti-malarial IgG subclass pattern are associated with severe Plasmodium falciparum malaria in Saudi children. Nasr A; Aljada A; Hamid O; Elsheikh HA; Masuadi E; Al-Bawab A; Alenazi TH; Abushouk A; Salah AM Malar J; 2021 Sep; 20(1):376. PubMed ID: 34551786 [TBL] [Abstract][Full Text] [Related]
12. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease. Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967 [TBL] [Abstract][Full Text] [Related]
13. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients. Wang Z; Xu Y; Zhou H; Wang Y; Li W; Lu Z; Jiang Z; Gu X; Zheng H; Zeng L; Huang P; Zhang L; Gu X Cardiovasc Ther; 2020; 2020():3568608. PubMed ID: 32256707 [TBL] [Abstract][Full Text] [Related]
14. FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy. Tanaka Y; Suzuki Y; Tsuge T; Kanamaru Y; Horikoshi S; Monteiro RC; Tomino Y Nephrol Dial Transplant; 2005 Nov; 20(11):2439-45. PubMed ID: 16221721 [TBL] [Abstract][Full Text] [Related]
15. Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease. Kuo HC; Wong HS; Chang WP; Chen BK; Wu MS; Yang KD; Hsieh KS; Hsu YW; Liu SF; Liu X; Chang WC Circ Cardiovasc Genet; 2017 Oct; 10(5):e001625. PubMed ID: 29025760 [TBL] [Abstract][Full Text] [Related]
16. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array. Kuo HC; Chang JC; Kuo HC; Yu HR; Wang CL; Lee CP; Huang LT; Yang KD Arthritis Rheumatol; 2015 Mar; 67(3):828-36. PubMed ID: 25470559 [TBL] [Abstract][Full Text] [Related]
17. Fcgamma receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Omi K; Ohashi J; Patarapotikul J; Hananantachai H; Naka I; Looareesuwan S; Tokunaga K Parasitol Int; 2002 Dec; 51(4):361-6. PubMed ID: 12421634 [TBL] [Abstract][Full Text] [Related]
18. Distribution of FcgammaRIIa and FcgammaRIIIb genotypes in patients with generalized aggressive periodontitis. de Souza RC; Colombo AP J Periodontol; 2006 Jul; 77(7):1120-8. PubMed ID: 16805673 [TBL] [Abstract][Full Text] [Related]
19. FcgammaRIIA, FcgammaRIIIA and FcgammaRIIIB polymorphisms in Spanish patients with systemic lupus erythematosus. González-Escribano MF; Aguilar F; Sánchez-Román J; Núñez-Roldán A Eur J Immunogenet; 2002 Aug; 29(4):301-6. PubMed ID: 12121275 [TBL] [Abstract][Full Text] [Related]
20. Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children. Ouma C; Davenport GC; Garcia S; Kempaiah P; Chaudhary A; Were T; Anyona SB; Raballah E; Konah SN; Hittner JB; Vulule JM; Ong'echa JM; Perkins DJ Hum Genet; 2012 Feb; 131(2):289-99. PubMed ID: 21818580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]